| scholarly article | Q13442814 |
| P50 | author | Tonya M Colpitts | Q54435531 |
| Ruth R Montgomery | Q56373575 | ||
| Erol Fikrig | Q28355961 | ||
| P2093 | author name string | Michael J Conway | |
| P2860 | cites work | Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection | Q21144412 |
| West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior | Q21563617 | ||
| Female-specific insect lethality engineered using alternative splicing. | Q51061299 | ||
| Insect population control using a dominant, repressible, lethal genetic system. | Q52577661 | ||
| West Nile virus | Q64127859 | ||
| Evidence for the Existence of a Pseudoknot Structure at the 3‘ Terminus of the Flavivirus Genomic RNA † | Q22337292 | ||
| Molecular biology of flaviviruses | Q23311397 | ||
| Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts | Q24276401 | ||
| Induction of direct antimicrobial activity through mammalian toll-like receptors | Q24290864 | ||
| Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I | Q24298724 | ||
| Phylogeny of the genus Flavivirus | Q24471099 | ||
| Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera | Q24570052 | ||
| Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases | Q24570064 | ||
| Virus and antibody dynamics in acute west nile virus infection | Q24570066 | ||
| Pathogenomics of Culex quinquefasciatus and meta-analysis of infection responses to diverse pathogens | Q24629550 | ||
| The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus | Q24645420 | ||
| Migratory birds and spread of West Nile virus in the Western Hemisphere | Q24653883 | ||
| The enhancement of arbovirus transmission and disease by mosquito saliva is associated with modulation of the host immune response | Q24657806 | ||
| DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells | Q24673466 | ||
| CCR5 deficiency increases risk of symptomatic West Nile virus infection | Q24677652 | ||
| Complement activation is required for induction of a protective antibody response against West Nile virus infection | Q27469834 | ||
| Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses | Q27469841 | ||
| Essential role of cyclization sequences in flavivirus RNA replication | Q27469848 | ||
| Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis | Q27470828 | ||
| Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival | Q27472671 | ||
| Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus | Q27472711 | ||
| West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection | Q27472821 | ||
| A Single Amino Acid Substitution in the West Nile Virus Nonstructural Protein NS2A Disables Its Ability To Inhibit Alpha/Beta Interferon Induction and Attenuates Virus Virulence in Mice | Q27473041 | ||
| West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling | Q27473048 | ||
| B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. | Q27473103 | ||
| CTL recognition of west Nile virus-infected fibroblasts is cell cycle dependent and is associated with virus-induced increases in class I MHC antigen expression | Q27473112 | ||
| Triaryl pyrazoline compound inhibits flavivirus RNA replication | Q27473130 | ||
| Engineering RNA interference-based resistance to dengue virus type 2 in genetically modified Aedes aegypti | Q27473167 | ||
| Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus | Q27473186 | ||
| Gamma Interferon Plays a Crucial Early Antiviral Role in Protection against West Nile Virus Infection | Q27473224 | ||
| PKR and RNase L Contribute to Protection against Lethal West Nile Virus Infection by Controlling Early Viral Spread in the Periphery and Replication in Neurons | Q27473291 | ||
| Host heterogeneity dominates West Nile virus transmission | Q27477600 | ||
| Interferon antagonist function of Japanese encephalitis virus NS4A and its interaction with DEAD-box RNA helicase DDX42. | Q33347656 | ||
| Discovery of insect and human dengue virus host factors | Q33435283 | ||
| The Imd pathway is involved in antiviral immune responses in Drosophila. | Q33510672 | ||
| OAS1 polymorphisms are associated with susceptibility to West Nile encephalitis in horses | Q33580157 | ||
| Persistence of West Nile virus in the central nervous system and periphery of mice | Q33586206 | ||
| Dengue virus inhibits immune responses in Aedes aegypti cells | Q33587333 | ||
| Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-presenting cells during West Nile virus infection | Q33641517 | ||
| Antibodies against a tick protein, Salp15, protect mice from the Lyme disease agent | Q33745554 | ||
| Induction of a peptide with activity against a broad spectrum of pathogens in the Aedes aegypti salivary gland, following Infection with Dengue Virus | Q33797819 | ||
| Interplay of RNA elements in the dengue virus 5' and 3' ends required for viral RNA replication | Q33877404 | ||
| Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoes | Q33905288 | ||
| Laboratory-acquired West Nile virus infections--United States, 2002. | Q33963829 | ||
| Neurologic manifestations and outcome of West Nile virus infection | Q33967282 | ||
| Differential modulation of murine host immune response by salivary gland extracts from the mosquitoes Aedes aegypti and Culex quinquefasciatus | Q33979004 | ||
| Saliva of the Yellow Fever mosquito, Aedes aegypti, modulates murine lymphocyte function | Q33983036 | ||
| Aedes aegypti salivary gland extracts modulate anti-viral and TH1/TH2 cytokine responses to sindbis virus infection | Q33984588 | ||
| Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study | Q33988636 | ||
| Potentiation of West Nile encephalitis by mosquito feeding | Q33994356 | ||
| Enhanced early West Nile virus infection in young chickens infected by mosquito bite: effect of viral dose | Q33998372 | ||
| Alterations in the Aedes aegypti transcriptome during infection with West Nile, dengue and yellow fever viruses | Q34016199 | ||
| Dengue virus capsid protein binds core histones and inhibits nucleosome formation in human liver cells | Q34016639 | ||
| Host genetic risk factors for West Nile virus infection and disease progression | Q34026212 | ||
| The Toll immune signaling pathway control conserved anti-dengue defenses across diverse Ae. aegypti strains and against multiple dengue virus serotypes | Q34047962 | ||
| Globalization, land use, and the invasion of West Nile virus | Q34055080 | ||
| CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission | Q34108023 | ||
| Phase II, randomized, double-blind, placebo-controlled, multicenter study to investigate the immunogenicity and safety of a West Nile virus vaccine in healthy adults | Q34154300 | ||
| A C-Type Lectin Collaborates with a CD45 Phosphatase Homolog to Facilitate West Nile Virus Infection of Mosquitoes | Q34195900 | ||
| Transmission of West Nile virus from an organ donor to four transplant recipients | Q34201110 | ||
| Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2 | Q34202698 | ||
| The peritrophic matrix of hematophagous insects | Q34263639 | ||
| Differential modulation of murine cellular immune responses by salivary gland extract of Aedes aegypti | Q34327255 | ||
| West Nile encephalitis: an emerging disease in the United States | Q34398570 | ||
| Surface phenotype and functionality of WNV specific T cells differ with age and disease severity | Q34403716 | ||
| IL-22 signaling contributes to West Nile encephalitis pathogenesis | Q34406318 | ||
| West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H | Q27477691 | ||
| CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System | Q27477717 | ||
| Engineering blood meal-activated systemic immunity in the yellow fever mosquito, Aedes aegypti | Q27477730 | ||
| An annotated catalogue of salivary gland transcripts in the adult female mosquito, Aedes aegypti | Q27478018 | ||
| Antiviral Peptides Targeting the West Nile Virus Envelope Protein | Q27478055 | ||
| Structure of Immature West Nile Virus | Q27480359 | ||
| Cell-Specific IRF-3 Responses Protect against West Nile Virus Infection by Interferon-Dependent and -Independent Mechanisms | Q27480936 | ||
| Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion | Q27481089 | ||
| CD40-CD40 Ligand Interactions Promote Trafficking of CD8+ T Cells into the Brain and Protection against West Nile Virus Encephalitis | Q27481468 | ||
| West Nile Virus-Induced Interferon Production Is Mediated by the Double-Stranded RNA-Dependent Protein Kinase PKR | Q27481501 | ||
| Protective immune responses against West Nile virus are primed by distinct complement activation pathways | Q27482651 | ||
| Differential Expression of Interferon (IFN) Regulatory Factors and IFN-Stimulated Genes at Early Times after West Nile Virus Infection of Mouse Embryo Fibroblasts | Q27484990 | ||
| Establishment and Maintenance of the Innate Antiviral Response to West Nile Virus Involves both RIG-I and MDA5 Signaling through IPS-1 | Q27485316 | ||
| Aedes aegypti uses RNA interference in defense against Sindbis virus infection | Q27485640 | ||
| Dysregulation of TLR3 Impairs the Innate Immune Response to West Nile Virus in the Elderly | Q27486578 | ||
| Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis | Q27486589 | ||
| West Nile virus infection of Drosophila melanogaster induces a protective RNAi response | Q27486650 | ||
| Interferon Regulatory Factor IRF-7 Induces the Antiviral Alpha Interferon Response and Protects against Lethal West Nile Virus Infection | Q27486785 | ||
| Tumor Necrosis Factor Alpha Protects against Lethal West Nile Virus Infection by Promoting Trafficking of Mononuclear Leukocytes into the Central Nervous System | Q27486917 | ||
| Matrix Metalloproteinase 9 Facilitates West Nile Virus Entry into the Brain | Q27486919 | ||
| Hyaluronidase of Bloodsucking Insects and Its Enhancing Effect on Leishmania Infection in Mice | Q27486947 | ||
| Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection | Q27487124 | ||
| West Nile virus infection in mosquitoes in the mid-south USA, 2002-2005 | Q27487311 | ||
| Evaluation of the function of a type I peritrophic matrix as a physical barrier for midgut epithelium invasion by mosquito-borne pathogens in Aedes aegypti | Q27487317 | ||
| Clinical Findings of West Nile Virus Infection in Hospitalized Patients, New York and New Jersey, 2000 | Q27487807 | ||
| Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man | Q27487937 | ||
| Persistent West Nile Virus Associated with a Neurological Sequela in Hamsters Identified by Motor Unit Number Estimation | Q27488303 | ||
| RNAi Targeting of West Nile Virus in Mosquito Midguts Promotes Virus Diversification | Q27488775 | ||
| Toll-like Receptor 7 Mitigates Lethal West Nile Encephalitis via Interleukin 23-Dependent Immune Cell Infiltration and Homing | Q27488876 | ||
| Effect of sequential exposure on infection and dissemination rates for West Nile and St. Louis encephalitis viruses in Culex quinquefasciatus | Q27489064 | ||
| The Immune Adaptor Molecule SARM Modulates Tumor Necrosis Factor Alpha Production and Microglia Activation in the Brainstem and Restricts West Nile Virus Pathogenesis | Q27489537 | ||
| The effects of midgut serine proteases on dengue virus type 2 infectivity of Aedes aegypti | Q27489631 | ||
| IL-10 Signaling Blockade Controls Murine West Nile Virus Infection | Q27489722 | ||
| Persistent West Nile virus infection in the golden hamster: studies on its mechanism and possible implications for other flavivirus infections | Q40506032 | ||
| Effect of mosquito midgut trypsin activity on dengue-2 virus infection and dissemination in Aedes aegypti | Q40508656 | ||
| A comparision of West Nile Virus transmission by Ochlerotatus trivittatus (COQ.), Culex pipiens (L.), and Aedes albopictus (Skuse). | Q40511345 | ||
| Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases | Q40514804 | ||
| Regulation of antigen processing and presentation molecules in West Nile virus-infected human skin fibroblasts. | Q40531456 | ||
| IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection | Q40551940 | ||
| Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. | Q40557733 | ||
| Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis | Q40571299 | ||
| Discovery of Aedes albopictus infected with west nile virus in southeastern Pennsylvania | Q40579939 | ||
| Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut | Q40628952 | ||
| Genetically engineered resistance to dengue-2 virus transmission in mosquitoes | Q40668453 | ||
| West Nile virus neuroinvasion and encephalitis induced by macrophage depletion in mice | Q40675894 | ||
| Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus | Q40676556 | ||
| Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF | Q40739302 | ||
| Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV. | Q41356673 | ||
| Aedes aegypti: model for blood finding strategy and prediction of parasite manipulation | Q41482153 | ||
| Characterization of the AeaHP gene and its expression in the mosquito Aedes aegypti (Diptera: Culicidae). | Q42673645 | ||
| Beta interferon controls West Nile virus infection and pathogenesis in mice | Q42780413 | ||
| Effects of Absence of Saliva on Blood Feeding by Mosquitoes | Q42979972 | ||
| Major histocompatibility complex class I (MHC-I) induction by West Nile virus: involvement of 2 signaling pathways in MHC-I up-regulation. | Q42982915 | ||
| Mosquito feeding-induced enhancement of Cache Valley Virus (Bunyaviridae) infection in mice | Q42988340 | ||
| The role of tumor necrosis factor in modulating responses of murine embryo fibroblasts by flavivirus, West Nile | Q42988570 | ||
| Effect of the Aedes fluviatilis saliva on the development of Plasmodium gallinaceum infection in Gallus (gallus) domesticus. | Q42990009 | ||
| Evidence of vertical transmission of West Nile virus in field-collected mosquitoes | Q42998396 | ||
| Blood-feeding in mosquitoes: probing time and salivary gland anti-haemostatic activities in representatives of three genera (Aedes, Anopheles, Culex). | Q42999153 | ||
| Simulium vittatum (Diptera: Simuliidae) and Lutzomyia longipalpis (Diptera: Psychodidae) salivary gland hyaluronidase activity | Q43000316 | ||
| Persistence of West Nile Virus in L-929 Mouse Fibroblasts | Q43000371 | ||
| Apoptosis in mosquito midgut epithelia associated with West Nile virus infection | Q43001064 | ||
| West Nile virus from female and male mosquitoes (Diptera: Culicidae) in subterranean, ground, and canopy habitats in Connecticut | Q43032020 | ||
| The salivary adenosine deaminase activity of the mosquitoes Culex quinquefasciatus and Aedes aegypti. | Q43032669 | ||
| Role of mosquito saliva in blood vessel location. | Q43032748 | ||
| Platelet-activating-factor-hydrolyzing phospholipase C in the salivary glands and saliva of the mosquito Culex quinquefasciatus. | Q43036324 | ||
| Early induction of interferon-independent virus-specific ICAM-1 (CD54) expression by flavivirus in quiescent but not proliferating fibroblasts--implications for virus-host interactions. | Q43039929 | ||
| The salivary purine nucleosidase of the mosquito, Aedes aegypti. | Q43041237 | ||
| Cultivation of various arboviruses in new transplantable lines of mouse fibroblasts | Q43420274 | ||
| Variations in feeding patterns of seven culicine mosquitoes on vertebrate hosts in Weld and Larimer Counties, Colorado | Q44155483 | ||
| A novel secreted endonuclease from Culex quinquefasciatus salivary glands. | Q44169035 | ||
| Transmission of West Nile virus by organ transplantation | Q45520511 | ||
| West Nile virus infection alters midgut gene expression in Culex pipiens quinquefasciatus Say (Diptera: Culicidae) | Q27489826 | ||
| An evolutionary conserved function of the JAK-STAT pathway in anti-dengue defense | Q27490202 | ||
| Tregs control the development of symptomatic West Nile virus infection in humans and mice | Q27490259 | ||
| Arbovirus transmission by Culex nigripalpus in Florida, 2005 | Q27490277 | ||
| Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection | Q27490290 | ||
| Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus | Q27490423 | ||
| Persistent Infection with West Nile Virus Years after Initial Infection | Q27490502 | ||
| Immature Dengue Virus: A Veiled Pathogen? | Q27490592 | ||
| Tissue tropism and neuroinvasion of West Nile virus do not differ for two mouse strains with different survival rates | Q27490872 | ||
| IPS-1 Is Essential for the Control of West Nile Virus Infection and Immunity | Q27490889 | ||
| Female-specific flightless phenotype for mosquito control | Q27490962 | ||
| Structure of the dengue virus envelope protein after membrane fusion | Q27643009 | ||
| Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States | Q27860919 | ||
| Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis | Q27890381 | ||
| The Lyme disease agent exploits a tick protein to infect the mammalian host | Q28264022 | ||
| Interferon regulatory factor-1 (IRF-1) shapes both innate and CD8(+) T cell immune responses against West Nile virus infection | Q28508364 | ||
| The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cells | Q28594819 | ||
| Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis | Q29615108 | ||
| Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission | Q29615114 | ||
| Experimental infection of North American birds with the New York 1999 strain of West Nile virus | Q29616255 | ||
| RNA interference acts as a natural antiviral response to O'nyong-nyong virus (Alphavirus; Togaviridae) infection of Anopheles gambiae | Q29616263 | ||
| Stable introduction of a life-shortening Wolbachia infection into the mosquito Aedes aegypti | Q29616268 | ||
| The outbreak of West Nile virus infection in the New York City area in 1999 | Q29618175 | ||
| Role of CD8+ T cells in control of West Nile virus infection | Q29619668 | ||
| West Nile virus: a primer for the clinician | Q29620970 | ||
| Epidemiology of West Nile virus in Connecticut: a five-year analysis of mosquito data 1999-2003. | Q30981765 | ||
| Identification of compounds with anti-West Nile Virus activity | Q33236579 | ||
| Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion | Q33238490 | ||
| Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen | Q33244670 | ||
| Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription | Q37596892 | ||
| Vaccines and immunotherapeutics for the prevention and treatment of infections with West Nile virus | Q37842337 | ||
| The virology, epidemiology, and clinical impact of West Nile virus: a decade of advancements in research since its introduction into the Western Hemisphere | Q37845954 | ||
| Modulation of dengue virus infection of dendritic cells by Aedes aegypti saliva | Q38860615 | ||
| Study on West Nile virus persistence in monkeys | Q38892318 | ||
| Vector competence of three North American strains of Aedes albopictus for West Nile virus. | Q39431171 | ||
| Changes in Aedes albopictus (Diptera: Culicidae) populations in New Jersey and implications for arbovirus transmission | Q39901265 | ||
| Functional importance of dengue virus maturation: infectious properties of immature virions | Q39917068 | ||
| CD8+ T cells use TRAIL to restrict West Nile virus pathogenesis by controlling infection in neurons | Q40282121 | ||
| Delayed mortality in a cohort of persons hospitalized with West Nile virus disease in Colorado in 2003. | Q40308164 | ||
| Persistence of West Nile virus immunoglobulin M antibodies, Greece | Q40315454 | ||
| prM-antibody renders immature West Nile virus infectious in vivo | Q40320862 | ||
| Variability in the 2'-5'-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease. | Q40344391 | ||
| The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system | Q40347486 | ||
| Primary causes of death in reported cases of fatal West Nile Fever, United States, 2002-2006. | Q40351958 | ||
| Development and characterization of non-glycosylated E and NS1 mutant viruses as a potential candidate vaccine for West Nile virus | Q40374575 | ||
| Characterization of the functional requirements of West Nile virus membrane fusion | Q40377031 | ||
| Specific interaction of capsid protein and importin-alpha/beta influences West Nile virus production | Q40381483 | ||
| Seasonal blood-feeding behavior of Culex tarsalis (Diptera: Culicidae) in Weld County, Colorado, 2007. | Q40392818 | ||
| Host selection by Culex pipiens mosquitoes and West Nile virus amplification | Q40398052 | ||
| Interferon and interferon-induced chemokine expression is associated with control of acute viremia in West Nile virus-infected blood donors | Q40411174 | ||
| The memory T cell response to West Nile virus in symptomatic humans following natural infection is not influenced by age and is dominated by a restricted set of CD8+ T cell epitopes | Q40414910 | ||
| Persistence of antibodies to West Nile virus nonstructural protein 5. | Q40419569 | ||
| Comprehensive analysis of west nile virus-specific T cell responses in humans | Q40421352 | ||
| Multiple regions in dengue virus capsid protein contribute to nuclear localization during virus infection | Q40421409 | ||
| Culex pipiens (Diptera: Culicidae): a bridge vector of West Nile virus to humans | Q40426736 | ||
| CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis | Q40427889 | ||
| Relative susceptibilties of South Texas mosquitoes to infection with West Nile virus | Q40435188 | ||
| Vector competence of Culiseta incidens and Culex thriambus for West Nile virus. | Q40457580 | ||
| Risk factors for encephalitis and death from West Nile virus infection. | Q40479908 | ||
| Single nucleotide polymorphisms in genes for 2'-5'-oligoadenylate synthetase and RNase L inpatients hospitalized with West Nile virus infection | Q40495949 | ||
| Ultrastructural study of West Nile virus pathogenesis in Culex pipiens quinquefasciatus (Diptera: Culicidae). | Q40505963 | ||
| Avian host and mosquito (Diptera: Culicidae) vector competence determine the efficiency of West Nile and St. Louis encephalitis virus transmission | Q40505972 | ||
| Mosquito saliva causes enhancement of West Nile virus infection in mice | Q34529854 | ||
| West Nile Fever Characteristics among Viremic Persons Identified through Blood Donor Screening | Q34623850 | ||
| Experimental infections with West Nile virus | Q34624485 | ||
| A paradoxical role for neutrophils in the pathogenesis of West Nile virus | Q34644801 | ||
| Replication and gene function in Kunjin virus | Q34705800 | ||
| Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic | Q34733732 | ||
| West nile virus RNA not detected in urine of 40 people tested 6 years after acute West Nile virus disease | Q34763947 | ||
| Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus | Q34833960 | ||
| Developing arbovirus resistance in mosquitoes | Q34843659 | ||
| Keratinocytes are cell targets of West Nile virus in vivo | Q35076652 | ||
| The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway | Q35122610 | ||
| Innate immune control of West Nile virus infection | Q35382179 | ||
| Genetic variants and susceptibility to neurological complications following West Nile virus infection | Q35466057 | ||
| A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection | Q35586915 | ||
| Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses | Q35702608 | ||
| West Nile virus: a growing concern? | Q35746093 | ||
| West Nile virus infection: a pediatric perspective | Q35762250 | ||
| Host feeding patterns of Culex mosquitoes and West Nile virus transmission, northeastern United States | Q35793987 | ||
| Analyzing the control of mosquito-borne diseases by a dominant lethal genetic system | Q35807850 | ||
| West Nile virus risk assessment and the bridge vector paradigm | Q35817345 | ||
| West Nile virus: where are we now? | Q35874060 | ||
| Relationships between infection, dissemination, and transmission of West Nile virus RNA in Culex pipiens quinquefasciatus (Diptera: Culicidae). | Q35874085 | ||
| Chemokine receptor Ccr2 is critical for monocyte accumulation and survival in West Nile virus encephalitis | Q36109370 | ||
| The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes | Q36132065 | ||
| Development of effective therapies against West Nile virus infection | Q36322125 | ||
| West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection | Q36418554 | ||
| Densoviruses for control and genetic manipulation of mosquitoes | Q36601841 | ||
| Immunopathology of flavivirus infections | Q36673924 | ||
| The continuing spread of West Nile virus in the western hemisphere | Q36945748 | ||
| Fusion loop peptide of the West Nile virus envelope protein is essential for pathogenesis and is recognized by a therapeutic cross-reactive human monoclonal antibody | Q36950014 | ||
| TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis | Q37120117 | ||
| Inhibition of neutrophil function by two tick salivary proteins | Q37204467 | ||
| The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness | Q37543198 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | West Nile virus | Q158856 |
| P304 | page(s) | 635-648 | |
| P577 | publication date | 2012-10-01 | |
| P1433 | published in | Clinical Microbiology Reviews | Q5133777 |
| P1476 | title | West Nile Virus: biology, transmission, and human infection | |
| P478 | volume | 25 |
| Q27927984 | A Mouse Model of Chronic West Nile Virus Disease |
| Q37632418 | A brief report of West Nile Virus neuroinvasive disease in the summer of 2012 in Hamilton, Ontario |
| Q26745536 | A glance at subgenomic flavivirus RNAs and microRNAs in flavivirus infections |
| Q40102642 | A gradient-free method for the purification of infective dengue virus for protein-level investigations |
| Q37708659 | A review of the epidemiological and clinical aspects of West Nile virus |
| Q38950405 | Age-related alterations in immune responses to West Nile virus infection. |
| Q38866173 | An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection |
| Q37399024 | Antibodies to West Nile virus in wild and farmed crocodiles in southeastern Mexico |
| Q27755387 | Approved Antiviral Drugs over the Past 50 Years |
| Q64933388 | Arboviral screening of invasive Aedes species in northeastern Turkey: West Nile virus circulation and detection of insect-only viruses. |
| Q33909344 | Assurance of neuroattenuation of a live vaccine against West Nile virus: a comprehensive study of neuropathogenesis after infection with chimeric WN/DEN4Δ30 vaccine in comparison to two parental viruses and a surrogate flavivirus reference vaccine. |
| Q38228539 | Basics of virology. |
| Q35138507 | Cerebrospinal fluid biomarker candidates associated with human WNV neuroinvasive disease |
| Q38836317 | Characterization of Puerto Rican West Nile Virus isolates in mice |
| Q39548265 | Chikungunya virus and West Nile virus infections imported into Belgium, 2007-2012. |
| Q90249644 | Comparative models for human nasal infections and immunity |
| Q57468964 | Current and Future Therapeutic Strategies for Lentiviral Eradication from Macrophage Reservoirs |
| Q40933219 | Decreased Flight Activity in Culex pipiens (Diptera: Culicidae) Naturally Infected With Culex flavivirus |
| Q56332773 | Detection of Usutu, Sindbis, and Batai Viruses in Mosquitoes (Diptera: Culicidae) Collected in Germany, 2011⁻2016 |
| Q26314682 | Detection of dengue, west Nile virus, rickettsiosis and leptospirosis by a new real-time PCR strategy |
| Q38211715 | Donor-derived West Nile virus infection in solid organ transplant recipients: report of four additional cases and review of clinical, diagnostic, and therapeutic features |
| Q92662345 | Emergence and Associated Risk Factors of Vector Borne West Nile Virus Infection in Ilorin, Nigeria |
| Q30150901 | Emerging arboviral human diseases in Southern Europe |
| Q38153635 | Emerging infections of the central nervous system |
| Q101409866 | Epidemiological hypothesis testing using a phylogeographic and phylodynamic framework |
| Q91973444 | Error associated with estimates of Minimum Infection Rate for Endemic West Nile Virus in areas of low mosquito trap density |
| Q26995285 | European surveillance for West Nile virus in mosquito populations |
| Q37682015 | Experimental infection of house sparrows (Passer domesticus) with West Nile virus isolates of Euro-Mediterranean and North American origins. |
| Q40134177 | Experimental infection of rock pigeons (Columba livia) with three West Nile virus lineage 1 strains isolated in Italy between 2009 and 2012. |
| Q40671296 | Exploration of West Nile Virus Infection in Mouse Models |
| Q90798978 | Flavivirus infection-A review of immunopathogenesis, immunological response, and immunodiagnosis |
| Q24273313 | Flaviviruses in Europe: complex circulation patterns and their consequences for the diagnosis and control of West Nile disease |
| Q52579926 | Genetic characterization of a novel picorna-like virus in Culex spp. mosquitoes from Mozambique. |
| Q35620173 | Genetic diversity in the collaborative cross model recapitulates human West Nile virus disease outcomes. |
| Q59245607 | Global spatial assessment of Aedes aegypti and Culex quinquefasciatus: a scenario of Zika virus exposure |
| Q59353530 | Host genetic control of mosquito-borne Flavivirus infections |
| Q37673163 | IFN-dependent and -independent reduction in West Nile virus infectivity in human dermal fibroblasts |
| Q27468691 | Identification of Climatic Factors Affecting the Epidemiology of Human West Nile Virus Infections in Northern Greece |
| Q34037579 | Identification of genes critical for resistance to infection by West Nile virus using RNA-Seq analysis |
| Q58114982 | Immune correlates of protection from West Nile virus neuroinvasion and disease |
| Q37629959 | Immune markers associated with host susceptibility to infection with West Nile virus |
| Q36701531 | Implementation of NAT Screening for West Nile Virus and Experience with Seasonal Testing in Germany. |
| Q37512884 | Interleukin-17A Promotes CD8+ T Cell Cytotoxicity To Facilitate West Nile Virus Clearance |
| Q64082886 | Long-term surveillance defines spatial and temporal patterns implicating Culex tarsalis as the primary vector of West Nile virus |
| Q40222732 | Matrix-M™ adjuvanted envelope protein vaccine protects against lethal lineage 1 and 2 West Nile virus infection in mice |
| Q34973833 | Matrix-assisted laser desorption ionization--time of flight mass spectrometry: an emerging tool for the rapid identification of mosquito vectors |
| Q40103493 | Miniature bovine pancreatic trypsin inhibitors (m-BPTIs) of the West Nile virus NS2B-NS3 protease. |
| Q61803865 | Modeling Arboviral Infection in Mice Lacking the Interferon Alpha/Beta Receptor |
| Q37547686 | Mosquito saliva serine protease enhances dissemination of dengue virus into the mammalian host |
| Q36584038 | Neutralizing antibodies against West Nile virus identified directly from human B cells by single-cell analysis and next generation sequencing. |
| Q28085545 | New insights into innate immune restriction of West Nile virus infection |
| Q97597462 | On the correct interpretation of similarity index in codon usage studies: comparison with four other metrics and implications for Zika and West Nile virus |
| Q33875734 | Osteopontin facilitates West Nile virus neuroinvasion via neutrophil "Trojan horse" transport |
| Q58539447 | Phosphonate inhibitors of West Nile virus NS2B/NS3 protease |
| Q38771712 | Protein Interactions during the Flavivirus and Hepacivirus Life Cycle |
| Q33873771 | Reconstructing the recent West Nile virus lineage 2 epidemic in Europe and Italy using discrete and continuous phylogeography. |
| Q64134963 | Reemergence of West Nile Virus Infections in Southern Greece, 2017 |
| Q37082586 | Risk factors for West Nile virus infection and disease in populations and individuals |
| Q38836544 | Role of Immune Aging in Susceptibility to West Nile Virus. |
| Q33945548 | Serological, molecular and entomological surveillance demonstrates widespread circulation of West Nile virus in Turkey |
| Q55342874 | Silent infection of human dendritic cells by African and Asian strains of Zika virus. |
| Q90159999 | Single cell immune profiling of dengue virus patients reveals intact immune responses to Zika virus with enrichment of innate immune signatures |
| Q38189511 | Smuggling across the border: how arthropod-borne pathogens evade and exploit the host defense system of the skin |
| Q58122913 | Surveillance and Diagnosis of West Nile Virus in the Face of Flavivirus Cross-Reactivity |
| Q34784962 | Systems immunology reveals markers of susceptibility to West Nile virus infection |
| Q42209961 | The West Nile virus-like flavivirus Koutango is highly virulent in mice due to delayed viral clearance and the induction of a poor neutralizing antibody response |
| Q40249733 | The expansion of vector-borne diseases and the implications for blood transfusion safety: The case of West Nile Virus, dengue and chikungunya |
| Q28114688 | The human immune system’s response to carcinogenic and other infectious agents transmitted by mosquito vectors |
| Q22809893 | The role of viral persistence in flavivirus biology |
| Q98947195 | Using Climate to Explain and Predict West Nile Virus Risk in Nebraska |
| Q90692910 | Vaccination with Aedes aegypti AgBR1 Delays Lethal Mosquito-Borne Zika Virus Infection in Mice |
| Q60046445 | Viral-Induced Enhanced Disease Illness |
| Q38733889 | West Nile Virus Infection in Human and Mouse Cornea Tissue |
| Q27303511 | West Nile Virus Spreads Transsynaptically within the Pathways of Motor Control: Anatomical and Ultrastructural Mapping of Neuronal Virus Infection in the Primate Central Nervous System |
| Q91652126 | West Nile Virus Vaccine Design by T Cell Epitope Selection: In Silico Analysis of Conservation, Functional Cross-Reactivity with the Human Genome, and Population Coverage |
| Q90433010 | West Nile Virus and Related Flavivirus in European Wild Boar (Sus scrofa), Latium Region, Italy: A Retrospective Study |
| Q66679530 | West Nile Virus and Usutu Virus Co-Circulation in Europe: Epidemiology and Implications |
| Q26741185 | West Nile Virus in Europe and Safety of Blood Transfusion |
| Q64068443 | West Nile Virus infection in a renal transplant recipient resulting in polioencephalomylelitis, quadriplegia, and global brain atrophy |
| Q24273290 | West Nile virus documented in Indonesia from acute febrile illness specimens |
| Q37666750 | West Nile virus drug discovery |
| Q40170232 | West Nile virus infection in suspected febrile typhoid cases in Xinjiang, China |
| Q35592450 | West Nile virus positive blood donation and subsequent entomological investigation, Austria, 2014. |
| Q57216436 | West Nile virus transmission and human infection risk in Veneto (Italy): a modelling analysis |
| Q27468689 | West Nile virus transmission: results from the integrated surveillance system in Italy, 2008 to 2015 |
Search more.